Literature DB >> 16151807

Effects of thermal stress on tumor antigenicity and recognition by immune effector cells.

Valeria Milani1, Elfriede Noessner.   

Abstract

The primary rationale for the application of clinical hyperthermia in the therapy of cancer is based on the direct cytotoxic effect of heat and the radio-chemosensitization of tumor cells. More recently, additional attention is given to the observation that heat and heat-shock proteins can activate the host's immune system. The expression of heat-shock genes and proteins provides an adaptive mechanism for stress tolerance, allowing cells to survive non-physiologic conditions. However, the same adaptive mechanism can ultimately favor malignant transformation by interfering with pathways that regulate cell growth and apoptosis. Cytoprotection and thermotolerance raised the concern that heat-treated tumor cells might also be resistant to attack by immune effector mechanisms. Many studies, including those from our group, address this concern and document that heat-exposure, although transiently modulating sensitivity to CTL, do not hinder CTL attack. Moreover, there are promising reports of heat-related upregulation of NK-activating ligands, rendering those tumors which have lost MHC class I molecules target for NK cell attack. Heat-induced cytoprotection, therefore, does not necessarily extend protection from cytotoxic immune mechanisms. When interpreting the effects of heat, it is important to keep in mind that thermal effects on cell physiology are strongly dependent on the thermal dose, which is a function of the magnitude of change in temperature and the duration of heat exposure. The thermal dose required to induce cell death in vitro strongly varies from cell type to cell type and depends on microenvironmental factors (Dewey 1994). Therefore, to dissect the immunological behaviour of a given tumor and its micro-environment at different thermal doses, it is essential to characterize the thermosensitivity of every single tumor type and assess the proportion of cells surviving a given heat treatment. In this review, we summarize the pleiotropic effects that heat exposure has on tumor cells. In particular, we focus on the effects of heat on the antigen presentation of tumor cells and their susceptibility to immune effector mechanisms. We emphasize that the response to thermal stress is not a one-time point event, but rather a time period starting with the heat exposure and extending over several days of recovery. In addition, the response of tumor cells and their susceptibility to immune effector cells is strongly dependent on the model system, on the magnitude and duration of the thermal stress and on the time of recovery after heat exposure. Consideration of these aspects might help to explain some of the conflicting results that are reported in the field of thermal stress response.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16151807     DOI: 10.1007/s00262-005-0052-3

Source DB:  PubMed          Journal:  Cancer Immunol Immunother        ISSN: 0340-7004            Impact factor:   6.968


  13 in total

1.  Hypothermia and surgery: immunologic mechanisms for current practice.

Authors:  Motaz Qadan; Sarah A Gardner; David S Vitale; David Lominadze; Irving G Joshua; Hiram C Polk
Journal:  Ann Surg       Date:  2009-07       Impact factor: 12.969

2.  Preliminary safety and efficacy results of laser immunotherapy for the treatment of metastatic breast cancer patients.

Authors:  Xiaosong Li; Gabriela L Ferrel; Maria C Guerra; Tomas Hode; John A Lunn; Orn Adalsteinsson; Robert E Nordquist; Hong Liu; Wei R Chen
Journal:  Photochem Photobiol Sci       Date:  2011-03-04       Impact factor: 3.982

3.  Use of warm Ringer's lactate solution in the management of locally advanced giant cell tumor of bone.

Authors:  Saranatra Waikakul; Apichat Asavamongkolkul; Rapin Phimolsarnti
Journal:  Int J Clin Oncol       Date:  2015-06-28       Impact factor: 3.402

4.  Fever-range whole body thermotherapy combined with oxaliplatin: a curative regimen in a pre-clinical breast cancer model.

Authors:  R Wanda Rowe; Frederick R Strebel; Jesse M Proett; Wanleng Deng; Diana Chan; Guangan He; Zahid Siddik; Joan M C Bull
Journal:  Int J Hyperthermia       Date:  2010       Impact factor: 3.914

5.  Variation of tumoral marker after radiofrequency ablation of pancreatic adenocarcinoma.

Authors:  Mirko D'Onofrio; Emilio Barbi; Roberto Girelli; Paolo Tinazzi Martini; Riccardo De Robertis; Valentina Ciaravino; Roberto Salvia; Giovanni Butturini; Isabella Frigerio; Teresa Milazzo; Stefano Crosara; Salvatore Paiella; Paolo Pederzoli; Claudio Bassi
Journal:  J Gastrointest Oncol       Date:  2016-04

6.  Haematoporphyrin based photodynamic therapy combined with hyperthermia provided effective therapeutic vaccine effect against colon cancer growth in mice.

Authors:  Yaoming He; Haiyan Ge; Shuping Li
Journal:  Int J Med Sci       Date:  2012-09-19       Impact factor: 3.738

7.  Cell-delivered magnetic nanoparticles caused hyperthermia-mediated increased survival in a murine pancreatic cancer model.

Authors:  Matthew T Basel; Sivasai Balivada; Hongwang Wang; Tej B Shrestha; Gwi Moon Seo; Marla Pyle; Gayani Abayaweera; Raj Dani; Olga B Koper; Masaaki Tamura; Viktor Chikan; Stefan H Bossmann; Deryl L Troyer
Journal:  Int J Nanomedicine       Date:  2012-01-18

8.  Preventive and promotive effects of habitual hot spa-bathing on the elderly in Japan.

Authors:  Toyoki Maeda; Koshi Mimori; Sadao Suzuki; Takahiko Horiuchi; Naoki Makino
Journal:  Sci Rep       Date:  2018-01-09       Impact factor: 4.379

9.  Mesothelioma cells escape heat stress by upregulating Hsp40/Hsp70 expression via mitogen-activated protein kinases.

Authors:  Michael Roth; Jun Zhong; Michael Tamm; John Szilard
Journal:  J Biomed Biotechnol       Date:  2009-06-17

10.  Inhibition of heat-shock protein 90 sensitizes liver cancer stem-like cells to magnetic hyperthermia and enhances anti-tumor effect on hepatocellular carcinoma-burdened nude mice.

Authors:  Rui Yang; Qiusha Tang; Fengqin Miao; Yanli An; Mengfei Li; Yong Han; Xihui Wang; Juan Wang; Peidang Liu; Rong Chen
Journal:  Int J Nanomedicine       Date:  2015-12-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.